MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Phase 3 Trial

Recent news which mentions Phase 3 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
Scynexis Aces Ibrexafungerp Late-Stage Study To Prevent Vaginal Yeast Infections
Tickers SCYX
Tags Phase 3 Trial Health Care Market News
From Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
Tickers ALKS
Tags Briefs ALKS Trading Ideas
From Benzinga
Cingulate Outlines Plan For Pivotal Attention Deficit/Hyperactivity Disorder Studies
Tickers CING
Tags CING Movers Health Care
From Benzinga
Why Are Vanda Pharma Shares Plunging Today?
Tickers VNDA
Tags Market News VNDA Health Care
From Benzinga
Anavex Life Sciences Says Rett Syndrome Trial Meets Primary & Secondary Goals
Tickers AVXL
Tags Phase 3 Trial AVXL News
From Benzinga
Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents
Tickers VALN
Tags News General Small Cap
From Benzinga
Madrigal Pharma's Kidney Disease Candidate Improves Liver, Cardiovascular Health
Tickers MDGL
Tags why it's moving Benzinga Biotech
From Benzinga
Why Are Tyme Technologies Shares Staring At 52-Week Low
Tickers TYME
Tags Phase 3 Trial Penny Stocks TYME
From Benzinga
FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease
Tickers ANVS
Tags News General Parkinson’s Disease
From Benzinga
Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation
Tickers ACHV
Tags News General ACHV
From Benzinga
Sierra Oncology Shares Rally As Bone Marrow Cancer Candidate Hits Primary Goal
Tickers SRRA
Tags Movers Health Care Market News
From Benzinga
Lyra Therapeutics Kickstarts LYR-210 Pivotal Program in Surgically Naïve Chronic Rhinosinusitis Patients
Tickers LYRA
Tags Health Care Phase 3 Trial Penny Stocks
From Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
Tickers SABS
Tags COVID/19 Coronavirus Market News Health Care
From Benzinga
FDA Approves Gilead's Remdesivir For Non-Hospitalized COVID-19 Patients At High Risk For Disease Progression
Tickers GILD
Tags Phase 3 Trial News General
From Benzinga
UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study
Tickers UCBJF UCBJY
Tags News General Market News
From Benzinga
Alnylam' Reveals Detailed 18-Month Data From Vutrisiran Trial In Inherited Disease
Tickers ALNY
Tags General News Health Care
From Benzinga
KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder
Tickers KMPH
Tags Market News Health Care KMPH
From Benzinga
Seres Therapeutics' Oral Microbiome Candidate Shows Meaningful Improvements In Difficile Infection
Tickers MCRB
Tags Briefs MCRB Trading Ideas
From Benzinga
EQRx's Sugemalimab Shows Significant Overall Survival Benefit In Lung Cancer Settings
Tickers EQRX
Tags Biotech Non/Small Cell Lung Cancer Benzinga
From Benzinga
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
Tickers REGN SNY
Tags Phase 3 Trial Health Care Market News
From Benzinga
Merck's Keytruda Manages To Cross The Finish Line In Liver Cancer Confirmatory Trial
Tickers MRK
Tags FDA Biotech Benzinga
From Benzinga
RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance
Tickers RDHL
Tags Benzinga RDHL Biotech
From Benzinga
Merck's Keytruda As Adjuvant Treatment Improves Disease-Free Survival In Lung Cancer Setting
Tickers MRK
Tags Biotech Benzinga Non/Small Cell Lung Cancer
From Benzinga
FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
Tickers RVPH
Tags General News Phase 3 Trial
From Benzinga
Oncternal, FDA In Pact For Pivotal Study Design For Zilovertam In Mantle Cell Lymphoma
Tickers ONCT
Tags Trading Ideas Briefs ONCT
From Benzinga
Early Data Shows Novavax's COVID-19 Vaccine Triggers Immune Response To Omicron
Tickers NVAX
Tags COVID/19 Vaccine COVID/19 Coronavirus Market News
From Benzinga
Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19
Tickers GILD
Tags COVID/19 Coronavirus News General
From Benzinga
Allakos' Shares Nosedive After Lirentelimab Studies Fail To Achieve Statistical Significance On Symptomatic Endpoints
Tickers ALLK
Tags ALLK Briefs Trading Ideas
From Benzinga
Valneva Posts Positive Lot-to-Lot Consistency Data For Its Single-Dose Chikungunya Vaccine
Tickers VALN
Tags News General VALN
From Benzinga
DBV Technologies To Conduct New Pivotal Trial For Peanut Allergy Patch, Shares Plunge To 52-Week Low
Tickers DBVT
Tags Biotech why it's moving Benzinga
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story